Skip to main content

Day: March 26, 2020

Corbion stelt Algemene vergadering van Aandeelhouders uit

Corbion stelt zijn Algemene vergadering van Aandeelhouders (AvA) uit naar 29 juni 2020 (de oorspronkelijke datum was 11 mei 2020).Dit besluit is genomen met het oog op de bescherming van de gezondheid en veiligheid van de deelnemers van de vergadering, in het licht van de impact van het coronavirus en de daarmee samenhangende maatregelen van de Nederlandse overheid.De convocatie en bijbehorende stukken zullen uiterlijk op 18 mei 2020 worden gepubliceerd.Dit persbericht bevat informatie die kwalificeert als voorwetenschap in de zin van artikel 7 lid 1 van de EU Marktmisbruik Verordening.BijlageUitstel_AvA_260320

Continue reading

OAK VALLEY COMMUNITY BANK ANNOUNCES COMMERCIAL LOAN OFFICER HIRING

OAKDALE, Calif., March 26, 2020 (GLOBE NEWSWIRE) — Oak Valley Community Bank, a wholly owned subsidiary of Oak Valley Bancorp (NASDAQ: OVLY), announced that Rafael Martinez has joined the bank as Assistant Vice President, Commercial Loan Officer. Martinez will be based out of the Turlock Office.Martinez has 10 years of banking experience. He will focus on commercial and agricultural lending in Turlock and other adjacent cities. “We are pleased to have Rafael join the commercial lending team,” stated Gary Stephens, EVP Commercial Banking Group. “His Central Valley roots and experience working with the local business and farming community will serve him well and help expand our lending efforts in the greater Turlock area.”Martinez received his Bachelor of Science Degree in Business Administration with a dual concentration in...

Continue reading

Tabula Rasa HealthCare® Names Frank Sparacino SVP Investor Relations and Corporate Development

MOORESTOWN, N.J., March 26, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare®, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, has named Frank Sparacino Senior Vice President of Investor Relations and Corporate Development. Sparacino will be responsible for overseeing TRHC’s interactions with the investment community and formalizing a corporate development function.“Frank is the ideal candidate to take on this important new role with Tabula Rasa HealthCare. He is a former sell side equity research analyst focused on the healthcare technology space and has covered Tabula Rasa for the past three years. During that time, we observed how dedicated Frank was to establishing a deep understanding of the company, our value proposition and our market opportunity,” said Chief Financial...

Continue reading

OSE Immunotherapeutics Reports 2019 Financial Results and Provides Business Update Expectations for Potential Impact of COVID-19 on the Company’s Clinical Development Activities

Strong clinical progress in lead assets Tedopi®, OSE-127 and BI 765063Bispecific antibody platform BiCKI®: First project selected, cytokine IL-7 to be paired with anti-PD-1 €5 million milestone payment from Servier accelerated and now expected by the start of a Phase 2 with OSE-127 in Sjögren’s syndrome FY 2019 turnover of €26 million2019 year-end cash position of €25.8 millionExpected €3 million research tax credit and Servier milestone to provide funding until Q1 2021NANTES, France, March 26, 2020 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today reported its consolidated annual financial results for 2019 and provided an update on key achievements, as well as the company’s outlook for its agonist and antagonist immunotherapies for cancers and autoimmune diseases.Alexis Peyroles, Chief Executive...

Continue reading

Ahold Delhaize successfully priced a 7-year €500 million senior bond issue

Zaandam, the Netherlands, March 26, 2020 – Koninklijke Ahold Delhaize N.V. announced today that it has successfully launched and priced €500 million fixed rate bonds due in 2027.The 7-year fixed rate bonds will bear a coupon of 1.75% per annum and were issued at a price of 99.44 per cent of the nominal value.The senior unsecured offering is expected to be assigned BBB/Baa1 credit ratings by S&P and Moody’s respectively. The bonds were placed with a broad range of institutional investors across Europe.The settlement of the bond issue will take place on April 2, 2020. The net proceeds from the offering will be applied for the refinancing of debt and for general corporate purposes.BNP PARIBAS, Goldman Sachs International, J.P. Morgan Securities plc and Merrill Lynch International acted as joint lead managers. The bonds will be listed...

Continue reading

SpareBank 1 SMN : Resolutions of the Supervisory Board

The Supervisory Board has at its meeting on 26 March 20120 adopted the following resolutions:Approval of the annual accounts for 2019, including application of the profit for the year.The supervisory board approved the board of directors’ proposal regarding the annual accounts and the management report for 2019.The supervisory board approved the board of directors’ revised proposal for application of the net profit, including payment of dividend of NOK 5.00 per equity certificate, altogether totalling NOK 647m, to equity certificate holders as at 26 March 2020 with payment taking place on 3 April 2020. SpareBank 1 SMN’s equity certificates are quoted ex dividend on 27 March 2020.The supervisory board also approved the board of directors’ revised recommendation to allocate NOK 364m to non-profit causes, of which NOK 164m goes to the foundation...

Continue reading

SpareBank 1 SMN: Vedtak i representantskapet

Representantskapet har i sitt møte 26. mars 2020 fattet følgende vedtak:Godkjennelse av årsregnskapet for 2019, herunder disponering av årsresultat.Representantskapet godkjente styrets forslag til årsregnskap og årsberetning for 2019.Representantskapet godkjente styrets reviderte forslag til anvendelse av overskudd, herunder utbetaling av utbytte på 5,00 kroner per egenkapitalbevis, samlet 647 mill. kroner, til egenkapitalbeviseiere per 26. mars 2020 med utbetaling 3. april 2020. Egenkapitalbevisene i SpareBank 1 SMN noteres «ex-utbytte» 27. mars 2020.Representantskapet godkjente videre styrets reviderte forslag om avsetting av 364 mill. kroner til allmennyttige formål, hvorav 164 mill. kroner tildeles Sparebankstiftelsen SMN og 200 mill. kroner til gaver til allmennyttige formål. Utjevningsfondet og grunnfondet tilføres henholdsvis 749...

Continue reading

2020 ANNUAL GENERAL MEETING OF SIKA AG

2020 ANNUAL GENERAL MEETING OF SIKA AGThe Board of Directors confirms April 21, 2020 as date for the Annual General MeetingBased on the Ordinance of the Federal Council on measures to prevent coronavirus, it will not be possible for shareholders to attend the Annual General Meeting in personAll current members of the Board of Directors are standing for re-electionThe Board of Directors confirms April 21, 2020 as date for the Annual General Meeting. This will ensure that all shareholders receive their dividend on time.All current members of the Board of Directors are standing for re-election. Instead of Frits van Dijk, who does not stand for re-election to the Nomination- and Compensation Committee, the Board of Directors proposes the election of Thierry Vanlancker.PERSONAL ATTENDANCE NOT PERMITTEDBased on the Ordinance of the Federal...

Continue reading

GENERALVERSAMMLUNG 2020 DER SIKA AG  

GENERALVERSAMMLUNG 2020 DER SIKA AGVerwaltungsrat bestätigt 21. April 2020 als Termin für die GeneralversammlungGestützt auf die vom Bundesrat erlassene Verordnung über die Massnahmen zur Bekämpfung des Coronavirus können Aktionäre nicht persönlich an der Generalversammlung teilnehmenAlle bisherigen Verwaltungsräte stellen sich zur WiederwahlDer Verwaltungsrat hat den 21. April 2020 als Termin für die Generalversammlung bestätigt. Damit ist gewährleistet, dass alle Aktionäre fristgerecht ihre Dividende erhalten.Alle bisherigen Verwaltungsräte stellen sich zur Wiederwahl. Anstelle von Frits van Dijk, der auf eine Wiederwahl in den Nominierungs- und Vergütungsausschuss verzichtet, schlägt der Verwaltungsrat die Wahl von Thierry Vanlancker vor.PERSÖNLICHE TEILNAHME NICHT MÖGLICHGestützt auf die vom Bundesrat erlassene Verordnung über die...

Continue reading

Nexstim Plc completes negotiations under the co-operation within undertakings act

Company announcement, insider information, Helsinki, 26 March 2020, at 7.00 pm (EET)Nexstim Plc completes negotiations under the co-operation within undertakings actNexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”),  announces that it has completed the co-operation negotiations.On 18 March 2020 the Company announced that it will initiate co-operation negotiations concerning all personnel in Finland, as a part of Nexstim Group cost savings plan aiming to reach up to EUR 3 million annual savings from its global operations.The co-operation negotiations in Finland have now ended and as a result, the Company decided to temporarily lay off all its personnel for maximum of 90 days. The lay offs may be executed as full time or part time lay offs. There were no terminations of employment in Finland. The cost savings...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.